---
figid: PMC2772740__zmb0210983170012
figlink: /pmc/articles/PMC2772740/figure/f12/
number: F12
caption: Schematic representation of pathways involved in NOR-1 upregulation by thrombin
  and VEGF (light lines) and hypoxia (bold lines) in endothelial cells. Thrombin and
  VEGF induce NOR-1 expression through a mechanism dependent on PAR-1 (protease-activated
  receptor-1) and VEGF receptor-2 (VEGFR-2/KDR), respectively, and multiple signaling
  pathways including cytosolic Ca2+, the activation of PKC, and MAPK pathways (both
  ERK1/2 and p38 MAPK) that lead to the downstream activation of CREB. VEGFR-2 can
  also activate Ras/Raf/MEK/ERK signaling. An increase in intracellular Ca2+ activates
  calcium/calmodulin-dependent kinases (Ca/CM). The potential cross talk among signaling
  pathways is indicated by dashed arrows. p90RSK, p38 MAPK, and Ca/CM are kinases
  potentially involved in CREB phosphorylation in Ser-133 (). The indicated cross
  talk mechanisms and kinases potentially involved in CREB phosphorylation have not
  been specifically analyzed in relation with NOR upregulation. Hypoxia increases
  intracellular Ca2+ concentration, which activates the PI3K/Akt pathway and its downstream
  target mTOR. The PI3K/Akt/mTOR pathway could mediate the upregulation of HIF-1α
  protein levels by decreasing HIF-1α degradation and/or increasing HIF-1α synthesis
  (, ). Agents that inhibit NOR-1 expression interfering signaling pathways are indicated
  (boxed). Arrows and T-bars indicate activation and inhibition, respectively. ATAP-2,
  anti-PAR-1 blocking antibody; DAG, diacylglycerol; IP3, inositol-1,4,5-triphosphate;
  PLC, phospholipase C; PTX, pertussis toxin.
pmcid: PMC2772740
papertitle: The Hypoxia-Inducible Factor 1/NOR-1 Axis Regulates the Survival Response
  of Endothelial Cells to Hypoxia .
reftext: Lluis Martorell, et al. Mol Cell Biol. 2009 Nov;29(21):5828-5842.
pmc_ranked_result_index: '15858'
pathway_score: 0.9608852
filename: zmb0210983170012.jpg
figtitle: Pathways involved in NOR-1 upregulation by thrombin and VEGF (light lines)
  and hypoxia (bold lines) in endothelial cells
year: '2009'
organisms:
- Homo sapiens
ndex: 83756da8-deb1-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2772740__zmb0210983170012.html
  '@type': Dataset
  description: Schematic representation of pathways involved in NOR-1 upregulation
    by thrombin and VEGF (light lines) and hypoxia (bold lines) in endothelial cells.
    Thrombin and VEGF induce NOR-1 expression through a mechanism dependent on PAR-1
    (protease-activated receptor-1) and VEGF receptor-2 (VEGFR-2/KDR), respectively,
    and multiple signaling pathways including cytosolic Ca2+, the activation of PKC,
    and MAPK pathways (both ERK1/2 and p38 MAPK) that lead to the downstream activation
    of CREB. VEGFR-2 can also activate Ras/Raf/MEK/ERK signaling. An increase in intracellular
    Ca2+ activates calcium/calmodulin-dependent kinases (Ca/CM). The potential cross
    talk among signaling pathways is indicated by dashed arrows. p90RSK, p38 MAPK,
    and Ca/CM are kinases potentially involved in CREB phosphorylation in Ser-133
    (). The indicated cross talk mechanisms and kinases potentially involved in CREB
    phosphorylation have not been specifically analyzed in relation with NOR upregulation.
    Hypoxia increases intracellular Ca2+ concentration, which activates the PI3K/Akt
    pathway and its downstream target mTOR. The PI3K/Akt/mTOR pathway could mediate
    the upregulation of HIF-1α protein levels by decreasing HIF-1α degradation and/or
    increasing HIF-1α synthesis (, ). Agents that inhibit NOR-1 expression interfering
    signaling pathways are indicated (boxed). Arrows and T-bars indicate activation
    and inhibition, respectively. ATAP-2, anti-PAR-1 blocking antibody; DAG, diacylglycerol;
    IP3, inositol-1,4,5-triphosphate; PLC, phospholipase C; PTX, pertussis toxin.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R6
  - AKT1
  - SETD2
  - RPS6KA5
  - UTS2
  - AKT2
  - AKT3
  - MAPK3
  - KDR
  - NRAS
  - RPS6KA3
  - RPS6KA4
  - PIK3R5
  - PLCB1
  - KRAS
  - BRAF
  - PLCD3
  - MAPK1
  - HIF1A
  - MAPK13
  - PLCB2
  - RPS6KA2
  - RPS6KA1
  - MAPK11
  - PIK3R3
  - PLCD4
  - PLCZ1
  - HRAS
  - RAF1
  - MAPK12
  - PLCB3
  - MAPK14
  - PIK3CA
  - PLCB4
  - RPS6KA6
  - PLCG1
  - PIK3CG
  - PLCG2
  - PLCD1
  - PLCE1
  - ARAF
  - PIK3R4
  - MTOR
  - PIK3CD
  - PIK3CB
  - BAPTA-AMH Ca
  - LY294002
  - SB203580
  - Rapamycin
  - Cancer
genes:
- word: PI3K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: HIF-1
  symbol: HIF-1
  source: hgnc_alias_symbol
  hgnc_symbol: SETD2
  entrez: '29072'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA5
  entrez: '9252'
- word: U0128HMEK1/2
  symbol: U-II
  source: hgnc_alias_symbol
  hgnc_symbol: UTS2
  entrez: '10911'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: VEGFR-2
  symbol: VEGFR2
  source: hgnc_alias_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA3
  entrez: '6197'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA4
  entrez: '8986'
- word: PI3K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB1
  entrez: '23236'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD3
  entrez: '113026'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: HIF-1a
  symbol: HIF-1alpha
  source: hgnc_alias_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: (p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB2
  entrez: '5330'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA2
  entrez: '6196'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA1
  entrez: '6195'
- word: (p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: PI3K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD4
  entrez: '84812'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCZ1
  entrez: '89869'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: (p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB3
  entrez: '5331'
- word: (p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: PI3K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB4
  entrez: '5332'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA6
  entrez: '27330'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: PI3K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD1
  entrez: '5333'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCE1
  entrez: '51196'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PI3K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI3K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
chemicals:
- word: BAPTA-AMH Ca
  source: MESH
  identifier: C025603
- word: LY294002
  source: MESH
  identifier: C085911
- word: SB203580
  source: MESH
  identifier: C093642
- word: Rapamycin
  source: MESH
  identifier: D020123
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC2772740__F12
redirect_from: /figures/PMC2772740__F12
figtype: Figure
---
